Illumina to divest cancer test maker Grail after antitrust battles – Reuters

​ 

​Illumina to divest cancer test maker Grail after antitrust battles  ReutersGene-Sequencing Company Illumina to Sell Cancer Test Developer  The New York TimesBiotech giant Illumina will unwind takeover of cancer-screening company Grail  ABC 10 News San Diego KGTVGrail spinoff by Illumina should end disastrous merger attempt – STAT  STAT 

Scroll to Top